M F Prescott
Overview
Explore the profile of M F Prescott including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
250
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hsiao H, Langenickel T, Petruck J, Kode K, Ayalasomayajula S, Schuehly U, et al.
Clin Pharmacol Ther
. 2017 Jun;
103(3):468-476.
PMID: 28599060
Sacubitril/valsartan (LCZ696) is indicated for the treatment of patients with heart failure and reduced ejection fraction (HFrEF). Since patients with HFrEF may receive sacubitril/valsartan and sildenafil, both increasing cyclic guanosine...
2.
Krone W, Hanefeld M, Meyer H, Jung T, Bartlett M, Yeh C, et al.
J Hum Hypertens
. 2010 Apr;
25(3):186-95.
PMID: 20376075
Metabolic syndrome, a cluster of risk factors that increase the risk of cardiovascular morbidity and mortality, is common in patients with hypertension. Chronic renin-angiotensin-aldosterone system (RAAS) activation, shown by elevated...
3.
Nussberger J, Gradman A, Schmieder R, Lins R, Chiang Y, Prescott M
Int J Clin Pract
. 2007 Jun;
61(9):1461-8.
PMID: 17590217
Background: Aliskiren is the first in a new class of orally effective renin inhibitors for the treatment of hypertension. Methods: In 569 patients with mild-to-moderate hypertension, blood pressure (BP), plasma...
4.
Hay C, Micko C, Prescott M, Liau G, Robinson K, De Leon H
Arterioscler Thromb Vasc Biol
. 2001 Dec;
21(12):1948-54.
PMID: 11742869
The heterogeneous nature of the cell populations involved in vascular repair remains a major hurdle for the assessment of the cellular events that take place in injured arteries. The present...
5.
Xu F, Prescott M, Liu P, Chen Z, Liau G, Gordon E, et al.
Int J Mol Med
. 2001 Jun;
8(1):19-30.
PMID: 11408944
Restenosis from neointimal proliferation is a frequent complication of intracoronary stenting and catheter-based revascularization procedures. Currently, there is no known therapeutic strategy that has been sufficiently effective to warrant its...
6.
Jeng A, Chou M, Sawyer W, Caplan S, JEUNE M, Prescott M
Ann N Y Acad Sci
. 1999 Jul;
878:555-8.
PMID: 10415771
No abstract available.
7.
Prescott M, Sawyer W, JEUNE M, Chou M, Caplan S, Jeng A
Ann N Y Acad Sci
. 1999 Jul;
878:179-90.
PMID: 10415729
The broad-spectrum MMP inhibitor CGS 27023A was tested to determine its potential as a therapy for atherosclerosis, aneurysm, and restenosis. LDL receptor-deficient (LDLr -/-) mice fed a high-fat, cholic acid-enriched...
8.
Feldman D, Mogelesky T, Sharif R, Sawyer W, JEUNE M, Hu C, et al.
Atherosclerosis
. 1999 Jul;
144(2):343-55.
PMID: 10407495
This report describes the in vitro and ex vivo antioxidant properties of a new antioxidant, CGP 2881. This compound is structurally similar to probucol, in that both compounds contain bis-tertiary...
9.
Bauriedel G, Schluckebier S, Hutter R, Welsch U, Kandolf R, Luderitz B, et al.
Arterioscler Thromb Vasc Biol
. 1998 Jul;
18(7):1132-9.
PMID: 9672074
Decreases in programmed cell death (apoptosis) may contribute to restenotic hyperplasia by prolonging the life span of intimal cells. Apoptotic events were compared in restenotic versus primary lesions, by using...
10.
Bauriedel G, Hutter R, Schluckebier S, Welsch U, Prescott M, Kandolf R, et al.
Z Kardiol
. 1997 Aug;
86(8):572-80.
PMID: 9417747
Restenosis remains a persistent problem following intravascular reconstruction. Smooth muscle cell proliferation, extracellular matrix production and remodeling are accepted mechanisms of restenotic lesion formation. Decreased programmed cell death (apoptosis) may...